Second Amendment to Consulting Agreement
Exhibit 10.3
Second Amendment to Consulting Agreement
This Second Amendment to Consulting Agreement (this “Second Amendment”) is entered into as of January 8, 2024 and is effective as of January 1, 2024, by and between Oramed Pharmaceuticals Inc., a company incorporated under the laws of the State of Delaware, with an address at 00 Xxxxxxx Xxx., Xxxxxxxxx, Xxxxxx 0000000 (the “Company”) and Shnida Ltd., a company incorporated under the laws of the State of Israel, (company I.D. no. 514519016) with an address at 00 Xxxxxxx Xxxxxxx Xxxxxx, Xxxxxxxxx (the “Consultant”).
WHEREAS, the Company and the Consultant entered into a consulting agreement, effective as of November 1, 2022 and amended as of April 27, 2023 (the “Consulting Agreement”); and
WHEREAS, the Company and the Consultant desire to amend the terms and conditions of the Consulting Agreement as set forth herein.
NOW, THEREFORE, the Company and the Consultant agree as follows:
| 1. | Amendment to Section 6. Section 6 of the Consulting Agreement is hereby amended and restated in its entirety to read as follows: |
Compensation. Effective January 1, 2024 (inclusive), the Company shall pay to the Consultant in consideration for the performance of the Consulting Services, a gross monthly amount of NIS 96,825 (the “Consideration”), subject to the receipt by the Company of an invoice from the Consultant.
| 2. | Except for the changes and/or additions stated herein, all the other terms of the Consulting Agreement shall remain valid and bind the parties without any change. In the case of a contradiction between the provisions of this Second Amendment and the provisions of the Consulting Agreement, the provisions of this Second Amendment shall prevail. Without limiting the generality of the foregoing, the term “Agreement” as used in the Consulting Agreement shall be deemed to be the Consulting Agreement as amended by this Second Amendment. |
IN WITNESS WHEREOF, the parties have executed this Second Amendment to Consulting Agreement as of the date Second written above.
| ORAMED PHARMACEUTICALS INC. | SHNIDA LTD. | |||
| By: | /s/ Xxxxx Xxxxxxxxx | By: | /s/ Xxxxx Xxxxxx | |
| Name: | Xxxxx Xxxxxxxxx | Name: | Xxxxx Xxxxxx | |
| Title: | Chief Financial Officer | Title: | Chief Executive Officer | |
I hereby confirm that I have read this Second Amendment, understood its terms and agree to be personally bound by all its terms and provisions.
| /s/ Xxxxx Xxxxxx | |
| Xxxxx Xxxxxx |
